Skip to Main Content
Home Books Harrison's Manual of Medicine, 20e

Chapter 193: Neuromyelitis Optica

INTRODUCTION

Neuromyelitis optica (NMO; Devic’s disease) is an aggressive inflammatory disorder characterized by recurrent attacks of optic neuritis (ON) and myelitis; the more inclusive term NMO Spectrum Disorders (NMOSD) incorporates pts with partial forms, and with involvement of additional CNS structures (Table 193-1). NMO is more frequent in women than men (>3:1), and typically begins in adulthood but can arise at any age. An important consideration is distinguishing between NMO and multiple sclerosis (MS; Chap. 192). In NMO, attacks of ON can be bilateral and produce severe visual loss (uncommon in MS); myelitis can be severe and transverse (rare in MS) and is typically longitudinally extensive (Fig. 193-1) involving three or more contiguous vertebral segments. Also in contrast to MS, progressive symptoms typically do not occur in NMO.

FIGURE 193-1

Imaging findings in neuromyelitis optica: longitudinally extensive transverse myelitis, optic neuritis and brainstem involvement. (A) Sagittal fluid attenuation inversion recovery (FLAIR) cervical-spine magnetic resonance image (MRI) showing an area of increased signal change on T2-weighted imaging spanning more than 3 vertebral segments in length. (B) Sagittal T1-weighted cervical-spine MRI following gadolinium-DPTA infusion showing enhancement. (C) Coronal brain MRI shows hyperintense signal on FLAIR imaging within the left optic nerve. (D) Coronal T1-weighted brain MRI following gadolinium-DPTA infusion shows enhancement of the left optic nerve. (E) Axial brain MRI shows an area of hyperintense signal on T2-weighted imaging within the area postrema (arrows). (F) Axial T1-weighted brain MRI following gadolinium-diethylene triamine pentaacetic acid (DPTA) infusion shows punctate enhancement of the area postrema (arrows).

6 images, A through F, of findings in neuromyelitis optica.
View Full Size||Download Slide (.ppt)
6 images, A through F, of findings in neuromyelitis optica.
TABLE 193-1Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorder
View Table||Download (.pdf)
TABLE 193-1 Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorder
Diagnostic Criteria for NMOSD with AQP4-IgG

  1. At least 1 core clinical characteristic

  2. Positive test for AQP4-IgG using best available detection method (cell-based assay strongly recommended)

  3. Exclusion of alternative diagnoses
Diagnostic Criteria for NMOSD without AQP4-IgG or NMOSD with Unknown AQP4-IgG Status

  1. At least 2 core clinical characteristics occurring as a result of one or more clinical attacks and meeting all of the following requirements:

    1. At least 1 core clinical characteristic must be optic neuritis, acute myelitis with LETM, or area postrema syndrome

    2. Dissemination in space (2 or more different clinical characteristics)

    3. Fulfillment of additional MRI requirements, as applicable

  2. Negative test for AQP4-IgG using best available detection method or testing unavailable

  3. Exclusion of alternative diagnoses
Core Clinical Characteristics

  1. Optic neuritis

  2. Acute myelitis

  3. Area postrema syndrome: episode of otherwise unexplained hiccups or nausea or vomiting

  4. Acute brainstem syndrome

  5. Symptomatic narcolepsy or acute diencephalic clinical syndrome with NMOSD-typical diencephalic MRI lesions

  6. Symptomatic cerebral syndrome with NMOSD-typical brain lesions
Additional MRI Requirements for NMOSD without AQP4-IgG and NMOSD with Unknown AQP4-IgG Status

  1. Acute optic neuritis: requires brain MRI showing (a) normal findings or only nonspecific white matter lesions, OR (b) optic nerve ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.

This site uses cookies to provide, maintain and improve your experience. MHE Privacy Center Close